Real-world study of Ceftazidime-Avibactam for the treatment of disease caused by bacteria: a plain language summary.

IF 2.5 4区生物学 Q3 MICROBIOLOGY

Future microbiology Pub Date : 2025-06-20 DOI:10.1080/17460913.2025.2515005

Alex Soriano, Philippe Montravers, Matteo Bassetti, Galina Klyasova, George Daikos, Paurus Irani, Gregory Stone, Pascale Peeters, Mitesh Shah, Claire Hulin, Benjamin Gaborit, Irene Kourbeti, Francesco Menichetti, Maria Teresa Perez-Rodriguez, Mathias W Pletz, Marisa Sanchez, Ivan Trompa, Anita Verma, Maria Lavinea N de Figueiredo, Claudie Charbonneau

引用次数: 0

查看原文本刊更多论文

头孢他啶-阿维巴坦治疗细菌引起的疾病的实际研究：简单的语言总结。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future microbiology 生物-微生物学

CiteScore

4.90

自引率

3.20%

发文量

134

审稿时长

6-12 weeks

期刊介绍： Future Microbiology delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this increasingly important and vast area of research.